Fatigue News and Research

RSS

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Brain areas involved in processing pain show altered activity in fibromyalgia patients

Feeling like we have a degree of control makes us tolerate pain better. In the case of fibromyalgia, however, this simply doesn’t work. A study provides clues as to why.

5 Apr 2023

Long-COVID fatigue reduced by over 50% in active individuals compared to sedentary

A recent Diagnostics journal study determined the impact of physical activity on sleep, fatigue, and cognitive modifications in individuals affected by long-COVID. This study investigates how long-COVID differentially affects individuals with active lives from those with sedentary lifestyles.

5 Apr 2023

Study suggests psychosocial factors, not acute infections, contribute to long-COVID in young adults

Researchers investigated the prevalence of post-coronavirus disease 2019 condition in adolescents and young adults

4 Apr 2023

SARS-CoV-2 infection significantly impacts cognitive function in patients with preexisting dementia

Infection with SARS-CoV-2 has a significant impact on cognitive function in patients with preexisting dementia, according to new research, published in the Journal of Alzheimer's Disease Reports.

4 Apr 2023

Social isolation linked to higher levels of tiredness

In a study conducted in the lab as well as during the COVID-19 lockdowns, participants reported higher levels of tiredness after eight hours of social isolation. The results suggest that low energy may be a basic human response to a lack of social contact.

4 Apr 2023

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.

4 Apr 2023

Fatigue is common among older adults, and it has many possible causes

Nothing prepared Linda C. Johnson of Indianapolis for the fatigue that descended on her after a diagnosis of stage 4 lung cancer in early 2020.

4 Apr 2023

Statins do not exacerbate muscle injury or pain after moderate-intensity exercise

Statin therapy does not exacerbate muscle injury, pain or fatigue in people engaging in moderate-intensity exercise, such as walking, according to a study published today in the Journal of the American College of Cardiology.

3 Apr 2023

What is the relationship between COVID-19 vaccination and the occurrence of long-COVID symptomatology?

Researchers evaluated the incidence of long coronavirus disease symptoms among COVID 2019 patients,

31 Mar 2023

Combating vaccine fatigue: Study offers actionable steps to boost acceptance

Researchers determine whether new vaccination campaigns must be adopted for primary and booster vaccination.

30 Mar 2023

CAR T-cell therapy improves quality of life for patients with blood cancers

Chimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, yet relatively few studies have investigated the impact of the therapy on longitudinal patient quality of life – an aspect of care that often suffers from receiving traditional intensive cancer medications, such as chemotherapy.

30 Mar 2023

New evidence: Fibromyalgia could worsen opioid use disorder

There is new evidence that fibromyalgia, and the chronic pain associated with it, could worsen opioid use disorder.

28 Mar 2023

The vital role of patients and the general public in guiding long-COVID research

In a recent study published in the journal Nature Medicine, researchers in the United Kingdom (UK) emphasized the significance of public and patient involvement (PPI) in scientific studies on long coronavirus disease (COVID).

27 Mar 2023

Study reveals the risk factors associated with developing long Covid

Being vaccinated against Covid halves people's risk of developing long Covid, according to new research from the University of East Anglia.

23 Mar 2023

Physical exercise can improve movement-related symptoms and quality of life in Parkinson's

In a recent review published in the Cochrane Database of Systematic Reviews, researchers in Germany performed a network meta-analysis (NMA) to evaluate the effectiveness of physical exercise in managing Parkinson's disease (PD) patients.

22 Mar 2023

Self-management support tool strengthens mental health in adults living with type 1 diabetes

International researchers -from the Netherlands, Germany, United Kingdom, and Spain- work together to develop an app that improves physical and emotional well-being in patients with type 1 diabetes mellitus (T1D).

22 Mar 2023

Can increasing nut intake prevent frailty in older women?

A recent study explored the potential for reducing frailty in older women by increased nut consumption.

22 Mar 2023

Supervised exercise training is safe and may improve quality of life for many people with heart failure

For many people who have heart failure, supervised exercise training is safe and may offer substantial improvement in exercise capacity and quality of life, even more than medications, according to a new, joint scientific statement from the American Heart Association and the American College of Cardiology.

21 Mar 2023

Sleep disorders contribute to cognitive dysfunction in women with multiple sclerosis

For women with multiple sclerosis who report cognitive dysfunction - one of the most common and disabling symptoms of the disease - sleep disorders such as insomnia and sleep apnea may contribute to the perceived decline, a Michigan Medicine study suggests.

21 Mar 2023

Fatigue News and Research

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

Brain areas involved in processing pain show altered activity in fibromyalgia patients

Long-COVID fatigue reduced by over 50% in active individuals compared to sedentary

Study suggests psychosocial factors, not acute infections, contribute to long-COVID in young adults

SARS-CoV-2 infection significantly impacts cognitive function in patients with preexisting dementia

Social isolation linked to higher levels of tiredness

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Fatigue is common among older adults, and it has many possible causes

Statins do not exacerbate muscle injury or pain after moderate-intensity exercise

What is the relationship between COVID-19 vaccination and the occurrence of long-COVID symptomatology?

Combating vaccine fatigue: Study offers actionable steps to boost acceptance

CAR T-cell therapy improves quality of life for patients with blood cancers

New evidence: Fibromyalgia could worsen opioid use disorder

The vital role of patients and the general public in guiding long-COVID research

Study reveals the risk factors associated with developing long Covid

Physical exercise can improve movement-related symptoms and quality of life in Parkinson's

Self-management support tool strengthens mental health in adults living with type 1 diabetes

Can increasing nut intake prevent frailty in older women?

Supervised exercise training is safe and may improve quality of life for many people with heart failure

Sleep disorders contribute to cognitive dysfunction in women with multiple sclerosis

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News